Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
377
datasets available to search
ShareScore release 0.9.0
Dataset results
377 results for “GLP-1”
GLP-1 Medicines and Mental Health Changes
ClinicalTrials.gov study NCT07368855. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
ClinicalTrials.gov study NCT07107334. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
ClinicalTrials.gov study NCT06801015. IPD Sharing: NO. Countries: 1. Publications: 0.
Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance
ClinicalTrials.gov study NCT01173978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
ClinicalTrials.gov study NCT02445508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
ClinicalTrials.gov study NCT02417103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)
ClinicalTrials.gov study NCT05468632. IPD Sharing: YES. Countries: 1. Publications: 0.
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
ClinicalTrials.gov study NCT01176708. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile, Gastric Emptying and GLP-1 Release in Normoglycemic and Prediabetic Subjects
ClinicalTrials.gov study NCT06789263. IPD Sharing: NO. Countries: 1. Publications: 0.
Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
ClinicalTrials.gov study NCT03648554. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
ClinicalTrials.gov study NCT05119179. IPD Sharing: NO. Countries: 1. Publications: 0.
Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
ClinicalTrials.gov study NCT01473147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.
ClinicalTrials.gov study NCT01043445. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
ClinicalTrials.gov study NCT07188545. IPD Sharing: NO. Countries: 1. Publications: 0.
GLP-1 RA on Liver OMICS in MASLD
ClinicalTrials.gov study NCT06982378. IPD Sharing: NO. Countries: 1. Publications: 0.
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U
ClinicalTrials.gov study NCT07218354. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
ClinicalTrials.gov study NCT06500429. IPD Sharing: NO. Countries: 1. Publications: 0.
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
ClinicalTrials.gov study NCT07091500. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
ClinicalTrials.gov study NCT06818292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Residual Gastric Content and GLP-1
ClinicalTrials.gov study NCT06814080. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.